Allon Therapeutics Inc — Form D

Allon Therapeutics Inc of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-17. The offering totals $2.9M, of which $1.6M was reported sold. Industry: Biotechnology.

Offering

Filed: 2012-05-17
Form: D
Accession: 0001183740-12-000313
Industry: Biotechnology
Exemptions: 06
Total offering: $2.9M
Amount sold: $1.6M
Remaining: $1.3M
Investors: 2
Date of first sale: 2012-05-01
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-178424

Issuer

Name: Allon Therapeutics Inc
CIK: 0001306079
Entity type: Corporation
Jurisdiction: CANADA (FEDERAL LEVEL)
Address: SUITE 506, 1168 HAMILTON STREET, VANCOUVER, A1, V6B 2S2
Phone: 604-734-5060

Officers, directors & promoters (12)

Name	Role	Location
MICHAEL G ALDRIDGE	Director	VANCOUVER, A1
MARTIN A BARKIN	Director	VANCOUVER, A1
ILLANA J GOZES	Director	VANCOUVER, A1
FRANK A HOLLER	Director	VANCOUVER, A1
GORDON C McCAULEY	Director	VANCOUVER, A1
JAMES J MILLER	Director	VANCOUVER, A1
ANTHONY G PHILLIPS	Director	VANCOUVER, A1
MATTHEW J CARLYLE	Executive Officer	VANCOUVER, A1
MICHAEL J GOLD	Executive Officer	VANCOUVER, A1
GORDON C McCAULEY	Executive Officer	VANCOUVER, A1
BRUCE H MORIMOTO	Executive Officer	VANCOUVER, A1
ALISTAIR H STEWART	Executive Officer	VANCOUVER, A1

More